Home - Ophthalmology 360

FDA approves Eysuvis for short-term treatment of dry eye disease

Retina Care 360

FDA approves first ophthalmic bevacizumab for wet AMD

The U.S. Food and Drug Administration has approved Lytenava (bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration (nAMD), making it the first FDA-approved ophthalmic formulation of bevacizumab for wet… …

Glaucoma

Rethinking the glaucoma visit: why the psychology of care matters as much as IOP

Dry Eye

Targeting inflammation in dry eye disease:a foundation for therapeutic intervention

Latest Videos

See All

Retina

ASRS 2026: ILUMIN-8 study shows real-world outcomes of aflibercept 8 mg in diabetic macular edema

The Interventional Glaucoma Project

Improving Patient Experience and Practice Workflow With an Interventional Glaucoma Approach

The Interventional Glaucoma Project

Data-Driven Focus on Interventional Glaucoma Care

Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

Conference Roundup

Epioxa crosslinking system has positive outcomes at 30 months in patients with keratoconus

Explore Topic Centers

Latest Podcasts

See All

Glaucoma

Redefining earlier intervention and long-term disease management in glaucoma

Podcasts

Should you consider a pathway to clinical vision research?

Glaucoma

Expanding the glaucoma treatment landscape with FLIGHT technology

Practice Management

ZEISS turns 100: the evolution of vision care, ophthalmology, and optical innovation

Retina

Nanoscope Therapeutics is working on the potential first-ever optogenetic therapy for retinal diseases

Retina

How Re-Vana is shaping the future of biodegradable drug delivery in retina care

Neurotrophic Keratitis

Early detection and targeted treatment strategies are critical for optimal outcomes in neurotrophic keratitis

Cataract

Meet the team behind the world’s first robotic cataract surgery

Latest Quizes

See All

Cornea and External Disease

Quiz: The impact of blepharitis and conjunctivitis on quality of life

Retina Care 360

Quiz: Mental health risks linked to age-related eye disease

Dry Eye

Quiz: Understanding meibomian gland dysfunction and its management

Dry Eye

Quiz: Emerging Therapies in DED

Cornea and External Disease

Quiz: Refractive Surgery in Patients With Diabetes

Neurotrophic Keratitis

Quiz: Topical Insulin for Persistent Corneal Epithelial Defects

Retinopathy of Prematurity

Quiz: ROP Pharmacologic Strategies

Subscribe to our newsletter

Get quick updates and the latest ophthalmology news delivered straight to your inbox.

Latest Content

FDA approves Eysuvis for short-term treatment of dry eye disease

Retina Care 360

FDA approves first ophthalmic bevacizumab for wet AMD

The U.S. Food and Drug Administration has approved Lytenava (bevacizumab-vikg) for the treatment of neovascular age-related macular degeneration (nAMD), making it the first FDA-approved ophthalmic formulation of bevacizumab for wet... ...

Glaucoma

Rethinking the glaucoma visit: why the psychology of care matters as much as IOP

By Savak Teymoorian, MD, MBA The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment recommendations. This...

Dry Eye

Targeting inflammation in dry eye disease:a foundation for therapeutic intervention

By Darrell E. White, MD The contents of this article are informational only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment recommendations. This...

Retina Care 360

Concurrent pegcetacoplan with anti-VEGF linked to slower geographic atrophy progression in nAMD

Concurrent treatment with pegcetacoplan and anti-VEGF injections was associated with a slower rate of geographic atrophy (GA) progression while maintaining stable visual acuity in patients with neovascular age-related macular degeneration...

Myopia

Red-light therapy outperforms low-dose atropine in altering macular morphology

Repeated low-level red-light (RLRL) therapy produced greater changes in 3D macular morphology than 0.01% low-dose atropine over 12 months in children with myopia, according to a study. The secondary analysis...

Glaucoma

Redefining earlier intervention and long-term disease management in glaucoma

In this episode of The Spotlight Series Podcast, host Mario Nacinovich sits down with Zarmeena Vendal, MD, of Westlake Eye Specialists, to discuss the growing role of interventional glaucoma in...

Retina

ASRS 2026: ILUMIN-8 study shows real-world outcomes of aflibercept 8 mg in diabetic macular edema

Michael Klufas, MD, spoke with Ophthalmology 360 about his presentation at the American Society of Retina Specialists 2026 Annual Meeting on real-world use of aflibercept in patients with diabetic macular...

7 Mins Watch

Cataract

Patients with oGVHD face higher risk of ocular surface complications after cataract surgery

Patients with ocular graft-versus-host disease (oGVHD) experienced significantly higher rates of postoperative ocular surface complications following cataract surgery than both patients without graft-versus-host disease and hematopoietic stem cell transplant (HSCT)...

Ophthalmology 360® Photo Contest

Submit your most captivating ophthalmic image to the Ophthalmology 360® Photo Contest. Top 3 winners receive $250

Ophthalmology 360® Photo Contest

Submit your most captivating ophthalmic image to the Ophthalmology 360® Photo Contest. Top 3 winners receive $250